vancomycin has been researched along with jbp 485 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Sun, H; Wang, C; Wen, S; Yang, S; Zhu, Y | 1 |
1 other study(ies) available for vancomycin and jbp 485
| Article | Year |
|---|---|
JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Cytoprotection; Disease Models, Animal; Gene Expression Regulation; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Organic Cation Transporter 2; Oxidative Stress; Peptides, Cyclic; Rats, Wistar; Renal Elimination; Vancomycin | 2018 |